Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis [Phase 3]
Phase 3 trial results evaluating tocilizumab with methotrexate versus monotherapy in treatment-naïve patients with early rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab [Phase 4]
Phase 4 trial evaluating etanercept in rheumatoid arthritis patients who lost response to adalimumab; study terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening [Phase 4]
A Phase 4 clinical trial update in rheumatoid arthritis patients with moderate to severe disease activity despite methotrexate (with or with…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis
This clinical trial update reports the efficacy and safety results of tocilizumab (RoActemra) in participants with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients
This update summarizes long-term outcomes for rheumatoid arthritis patients who demonstrated an early response to certolizumab pegol (Cimzia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients [Phase 2]
A Phase 2 efficacy trial of FANG(30) in adults with active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy. [Phase 3]
Phase 3 clinical trial update of Rituximab (MabThera) in rheumatoid arthritis patients with inadequate response to DMARDs and/or anti-TNF th…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)
This is a completed observational study evaluating the impact of RoActemra/Actemra on fatigue in patients with rheumatoid arthritis, with re…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study) [NA]
A clinical trial evaluating self-monitoring and internet-assisted management in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201 [Phase 2]
This document provides a Phase II open-label update on the long-term safety, tolerability, and efficacy of intravenous natalizumab in rheuma…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis [Phase 2]
Reports the completion of a Phase 2 efficacy and safety trial of R935788 tablets for rheumatoid arthritis, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)
This clinical trial update summarizes results from an observational study of tocilizumab (RoActemra/Actemra) in real-world rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Metal Ions in Ceramic on Metal Total Hip Arthroplasty
The ClinicalTrials.gov update indicates a completed study evaluating metal ion exposure in ceramic-on-metal total hip arthroplasty with resu…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
This completed clinical trial update describes therapeutic strategies for rheumatoid arthritis patients treated with methotrexate.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial in rheumatoid arthritis completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study of LY2439821 in Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial of LY2439821 in rheumatoid arthritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Study in Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial in rheumatoid arthritis sponsored by Eli Lilly and Company has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1]
Phase 1 clinical trial updating the use of human umbilical cord mesenchymal stem cells for rheumatoid arthritis. The study status is current…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) [Phase 3]
Phase 3 trial evaluating secukinumab in rheumatoid arthritis patients with inadequate response to anti-TNF therapy assessed efficacy at 24 w…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Acute Effect of Resistance Training in Inflammatory Markers in Women With Rheumatoid Arthritis [Phase 4]
Phase 4 trial assessing the acute effects of resistance training on inflammatory markers in women with rheumatoid arthritis; study completed…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Trial of a Physical Activity Intervention for RA Fatigue [NA]
This completed clinical trial evaluated a physical activity program to reduce fatigue in individuals with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Korean Post-marketing Surveillance for Orencia®
The document reports the completion of a Korean post-marketing surveillance study of Orencia (abatacept) for rheumatoid arthritis. It indica…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
A non-interventional study of tocilizumab (RoActemra/Actemra) in adults with moderate to severe rheumatoid arthritis has completed and resul…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Rhupus Syndrome and Efficacy of Etanercept Treatment
A completed clinical trial evaluated the efficacy of etanercept in rhupus syndrome, an overlap of rheumatoid arthritis and systemic lupus er…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Marine Oils and Arthritis [NA]
A clinical trial evaluating marine oils for rheumatoid arthritis was terminated; no definitive results are reported in this update.